These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32113159)

  • 1. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma.
    Li Y; Li CQ; Guo SJ; Guo W; Jiang HW; Li HC; Tao SC
    EBioMedicine; 2020 Mar; 53():102674. PubMed ID: 32113159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma.
    Chen G; Wang X; Yu J; Varambally S; Yu J; Thomas DG; Lin MY; Vishnu P; Wang Z; Wang R; Fielhauer J; Ghosh D; Giordano TJ; Giacherio D; Chang AC; Orringer MB; El-Hefnawy T; Bigbee WL; Beer DG; Chinnaiyan AM
    Cancer Res; 2007 Apr; 67(7):3461-7. PubMed ID: 17409457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis.
    Wang Y; Wang P; Liu M; Zhang X; Si Q; Yang T; Ye H; Song C; Shi J; Wang K; Wang X; Zhang J; Dai L
    J Immunol Methods; 2021 May; 492():112991. PubMed ID: 33587914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic efficiency of seven autoantibodies in lung cancer.
    Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
    Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
    J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.
    Zhang X; Li J; Wang Y; Liu M; Liu F; Zhang X; Pei L; Wang T; Jiang D; Wang X; Zhang J; Dai L
    Front Immunol; 2021; 12():728853. PubMed ID: 35140701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
    Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
    J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
    Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody biomarkers for the detection of serous ovarian cancer.
    Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS
    Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality.
    Evans RL; Pottala JV; Nagata S; Egland KA
    BMC Cancer; 2018 Jan; 18(1):119. PubMed ID: 29386014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
    Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
    Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
    Brichory FM; Misek DE; Yim AM; Krause MC; Giordano TJ; Beer DG; Hanash SM
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9824-9. PubMed ID: 11504947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum.
    Kilic A; Schuchert MJ; Luketich JD; Landreneau RJ; Lokshin AE; Bigbee WL; El-Hefnawy T
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):199-204. PubMed ID: 18603076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI-1 autoantibody as a new potential biomarker for cervical carcinoma.
    Tong YQ; Liu B; Zheng HY; He YJ; Gu J; Li F; Li Y
    PLoS One; 2011; 6(11):e27804. PubMed ID: 22132147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.
    Madoz-Gúrpide J; Kuick R; Wang H; Misek DE; Hanash SM
    Mol Cell Proteomics; 2008 Feb; 7(2):268-81. PubMed ID: 17916591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary Adenocarcinoma.
    Yanagita K; Nagashio R; Ryuge S; Katono K; Jiang SX; Tsuchiya B; Nakashima H; Fukuda E; Goshima N; Saegusa M; Satoh Y; Masuda N; Sato Y
    Asian Pac J Cancer Prev; 2015; 16(17):7959-65. PubMed ID: 26625826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.